$UMAC
Unusual Machines, Inc. Stock $umac

$umac Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000168316824008108 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4
Revenue		$1.531M	$0.00
YoY Change
Cost Of Revenue		$1.132M	$0.00
YoY Change
Gross Profit		$399.5K	$0.00
YoY Change
Gross Profit Margin		26.09%
Selling, General & Admin		$1.627M	$412.4K
YoY Change		360.98%	-11.1%
% of Gross Profit		407.33%
Research & Development		$15.00K
YoY Change
% of Gross Profit		3.75%
Depreciation & Amortization		$170.00	$4.200K
YoY Change		-71.67%	366.67%
% of Gross Profit		0.04%
Operating Expenses		$1.861M	$416.6K
YoY Change		426.02%	-10.37%
Operating Profit		-$1.461M	-$416.6K
YoY Change		313.08%	-10.37%
Interest Expense		$1.950K	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net		-$683.2K
YoY Change
Pretax Income		-$2.144M	-$416.6K
YoY Change		506.23%	-10.37%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		-$2.144M	-$416.6K
YoY Change		506.23%	-10.37%
Net Earnings / Revenue		-140.03%
Basic Earnings Per Share		-$0.30
Diluted Earnings Per Share		-$0.30	-$0.05
COMMON SHARES
Basic Shares Outstanding	8.300M shares	6.185M shares
Diluted Shares Outstanding		7.148M shares

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.686M	$894.8K
YoY Change	26.09%	-71.13%
Cash & Equivalents	$1.686M	$894.8K
Short-Term Investments
Other Short-Term Assets	$158.1K	$120.6K
YoY Change	-72.27%	-46.91%
Inventory	$1.453M	$0.00
Prepaid Expenses
Receivables	$79.91K	$0.00
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.517M	$1.528M
YoY Change	136.86%	-54.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$741.00	$1.254K
YoY Change	-86.53%	-66.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$20.01M	$1.254K
YoY Change	370404.0%	-66.11%
TOTAL ASSETS
Total Short-Term Assets	$4.517M	$1.528M
Total Long-Term Assets	$20.01M	$1.254K
Total Assets	$24.52M	$1.529M
YoY Change	1182.26%	-54.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.033M	$114.5K
YoY Change	1173.29%	-5.29%
Accrued Expenses	$19.08K	$0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.018M	$114.5K
YoY Change	2388.6%	-5.3%
LONG-TERM LIABILITIES
Long-Term Debt	$3.000M	$0.00
YoY Change
Other Long-Term Liabilities	$280.3K
YoY Change
Total Long-Term Liabilities	$3.280M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.018M	$114.5K
Total Long-Term Liabilities	$3.280M	$0.00
Total Liabilities	$5.299M	$114.5K
YoY Change	6433.34%	-5.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.796M	-$3.333M
YoY Change		116.63%
Common Stock	$61.85K	$32.17K
YoY Change		-5.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.23M	$1.415M
YoY Change
Total Liabilities & Shareholders Equity	$24.52M	$1.529M
YoY Change	1182.26%	-54.08%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	-$2.144M	-$416.6K
YoY Change	506.23%	-10.37%
Depreciation, Depletion And Amortization	$170.00	$4.200K
YoY Change	-71.67%	366.67%
Cash From Operating Activities	-$536.7K	-$442.3K
YoY Change	4.65%	-12.3%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$40.00
YoY Change	-100.0%	-101.9%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	$0.00	$40.00
YoY Change	-100.0%	-101.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-536.7K	-442.3K
Cash From Investing Activities	0.000	40.00
Cash From Financing Activities	0.000	0.000
Net Change In Cash	-536.7K	-442.3K
YoY Change	4.01%	-12.67%
FREE CASH FLOW
Cash From Operating Activities	-$536.7K	-$442.3K
Capital Expenditures	$0.00	-$40.00
Free Cash Flow	-$536.7K	-$442.3K
YoY Change	4.01%	-12.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Shell Company EntityShellCompany	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-270519
	dei	Entity Registrant Name EntityRegistrantName	Unusual Machines, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	66-0927642
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4677 L B McLeod Rd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite J
	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32811
	dei	City Area Code CityAreaCode	855
	dei	Local Phone Number LocalPhoneNumber	921-4600
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	UMAC
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8300480	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1685772	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	894773	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	79907	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	1453042	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2024Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	19666086	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	0	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001956955
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	514012	usd
CY2024Q3	us-gaap	Assets Assets	24524541	usd
CY2023Q4	us-gaap	Assets Assets	1529416	usd
CY2024Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1032636	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	114497	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	65089	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	300517	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan		usd
CY2024Q3	UMAC	Stock Issued During Period Value Exchange Of Common Shares For Series Preferred StockIssuedDuringPeriodValueExchangeOfCommonSharesForSeriesPreferred		usd
CY2024Q3	UMAC	Prepaid Inventory PrepaidInventory	1140511	usd
CY2023Q4	UMAC	Prepaid Inventory PrepaidInventory	0	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	158093	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	120631	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	4517325	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1015404	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	741	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1254	usd
CY2024Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	512758	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	340389	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	20007216	usd
CY2024Q3	UMAC	Warrant Liabilities Current WarrantLiabilitiesCurrent	308964	usd
CY2023Q4	UMAC	Warrant Liabilities Current WarrantLiabilitiesCurrent	0	usd
CY2024Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	311048	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2018254	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	114497	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	3000000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	0	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	280285	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2024Q3	us-gaap	Liabilities Liabilities	5298539	usd
CY2023Q4	us-gaap	Liabilities Liabilities	114497	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6184983	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6184983	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3217255	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3217255	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	61850	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	32173	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27959642	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5315790	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8795536	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3933046	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	19226002	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1414919	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24524541	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1529416	usd
CY2024Q3	us-gaap	Revenues Revenues	1531264	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	3561303	usd
	us-gaap	Revenues Revenues	0	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	1131777	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2569209	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	399487	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	0	usd
	us-gaap	Gross Profit GrossProfit	992094	usd
	us-gaap	Gross Profit GrossProfit	0	usd
CY2024Q3	UMAC	Operations Operations	218126	usd
CY2023Q3	UMAC	Operations Operations	0	usd
	UMAC	Operations Operations	544220	usd
	UMAC	Operations Operations	0	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42078	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	252253	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	0	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	795643	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	0	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1374989	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	353029	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3728749	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1965469	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	171	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	645	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	513	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1407	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	1860539	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	353674	usd
	us-gaap	Operating Expenses OperatingExpenses	5111203	usd
	us-gaap	Operating Expenses OperatingExpenses	1966876	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1461052	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-353674	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4119109	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1966876	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	180	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	180	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	41465	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	-0	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	101648	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	-0	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-685151	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-685151	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	43238	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	43238	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-683198	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-743381	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2144250	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-353674	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4862490	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1966876	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7147866	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7147866	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3217255	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3217255	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7749285	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7749285	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3337402	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3337402	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3198381	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	600000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1177904	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2620477	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-435298	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2185179	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-353674	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1831505	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1414919	usd
CY2024Q1	UMAC	Issuance Of Common Shares As Settlement IssuanceOfCommonSharesAsSettlement	64344	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3849555	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	17000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1106002	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	21222816	usd
CY2024Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	346854	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14389	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1612238	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	19971821	usd
CY2024Q3	UMAC	Stock Issued During Period Value Exchange Of Convertible Note For Series C Preferred StockIssuedDuringPeriodValueExchangeOfConvertibleNoteForSeriesCPreferred	1000000	usd
CY2024Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	375345	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23086	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2144250	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	19226002	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4862490	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1966876	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	513	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1407	usd
	UMAC	Stock Compensation Expense As Settlement StockCompensationExpenseAsSettlement	64344	usd
	UMAC	Stock Compensation Expense As Settlement StockCompensationExpenseAsSettlement	600000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	759673	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	UMAC	Change In Fair Value For Warrant And Derivative Liabilities ChangeInFairValueForWarrantAndDerivativeLiabilities	43239	usd
	UMAC	Change In Fair Value For Warrant And Derivative Liabilities ChangeInFairValueForWarrantAndDerivativeLiabilities	-0	usd
	UMAC	Gains Losses On Extinguishment Of Debt1 GainsLossesOnExtinguishmentOfDebt1	-663250	usd
	UMAC	Gains Losses On Extinguishment Of Debt1 GainsLossesOnExtinguishmentOfDebt1	-0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	73109	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-337562	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-0	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	319532	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-0	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	29100	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-33750	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	630595	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-50819	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-33056	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	186076	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2718513	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1382538	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	852801	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3164	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-852801	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3164	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	637687	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	376702	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4362313	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-376702	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	790999	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1762404	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	894773	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3099422	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1685772	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1337018	usd
	UMAC	Noncash Consideration Paid For Assets Acquired And Liabilities Assumed NoncashConsiderationPaidForAssetsAcquiredAndLiabilitiesAssumed	19000000	usd
	UMAC	Noncash Consideration Paid For Assets Acquired And Liabilities Assumed NoncashConsiderationPaidForAssetsAcquiredAndLiabilitiesAssumed	0	usd
	UMAC	Deferred Acquisition Costs DeferredAcquisitionCosts	100000	usd
	UMAC	Deferred Acquisition Costs DeferredAcquisitionCosts	0	usd
	UMAC	Deferred Offering Costs Recorded As Reduction Of Proceeds DeferredOfferingCostsRecordedAsReductionOfProceeds	512758	usd
	UMAC	Deferred Offering Costs Recorded As Reduction Of Proceeds DeferredOfferingCostsRecordedAsReductionOfProceeds	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zqxtljboF11g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_865_zlQcU7b8n0pe">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates, and such results could be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements include some amounts that are based on management's best estimates and judgments. Significant estimates reflected in these financial statements include those used to (i) determine stock-based compensation, (ii) the fair value of assets acquired and liabilities assumed in business combinations and the value of shares issued as consideration, (iii) reserves and allowances related to accounts receivable, inventory and sales, (iv) the evaluation of long-term assets, including goodwill, for impairment, (v) the fair value of lease liabilities and related right of use assets, the fair value of embedded conversion option derivatives and warrant liabilities, and (vi) the warranty liability reserve.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1400000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	600000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	512758	usd
	UMAC	Property Plant And Equipment Useful Life1 PropertyPlantAndEquipmentUsefulLife1	two to five years
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1149	pure
CY2024Q3	UMAC	Financial Liabilities Fair Value Warrant Liabilties FinancialLiabilitiesFairValueWarrantLiabilties	308964	usd
CY2024Q3	UMAC	Financial Liabilities Fair Value Derivative Liability FinancialLiabilitiesFairValueDerivativeLiability	311048	usd
CY2024Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	620012	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19080	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	0	usd
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p id="xdx_841_eus-gaap--RevenueRecognitionDeferredRevenue_zpeo6wpx2vf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86C_zQgFkUTVszk">Deferred Revenue</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue relates to (i) orders placed, but not yet fulfilled and (ii) customer tickets purchased related to the Company’s Rampage event, in which tickets are sold in advance and recognized when the event takes place. All deferred revenue is expected to be recognized within one year. Deferred revenue related to orders placed, but not yet fulfilled totaled $<span id="xdx_903_eus-gaap--DeferredRevenueCurrent_iI_c20240930_zDTdAOnds6z7" title="Deferred revenue">300,517</span> and $<span id="xdx_909_eus-gaap--DeferredRevenueCurrent_iI_c20231231_zxZukIS3uwC1" title="Deferred revenue">0</span> as of September 30, 2024 and December 31, 2023, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	300517	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<p id="xdx_848_eus-gaap--DerivativesEmbeddedDerivatives_zn1L41VjgWCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_868_zqjvohZyrDE7">Embedded Conversion Option Derivative </span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for embedded debt conversion features in accordance with the guidance in ASC 815, <i>Derivatives and Hedging</i> (“ASC 815”). If the embedded debt conversion feature is not clearly and closely related to the debt host, then it is required to be bifurcated from the host contract and accounted for separately as a derivative liability. The derivative liability is required to be recorded at its initial fair value on the date of issuance, and each balance sheet date, thereafter. Changes in the estimated fair value of the derivative are recognized as a non-cash gain or loss in the consolidated statements of operations and comprehensive loss. This assessment, which requires the use of professional judgment, is conducted at the time of Note issuance and as of each subsequent quarterly period end date while the Note is outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1453042	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2024Q3	UMAC	Prepaid Deposits For Inventory PrepaidDepositsForInventory	1140511	usd
CY2023Q4	UMAC	Prepaid And Deposits For Inventory PrepaidAndDepositsForInventory	0	usd
CY2024Q3	us-gaap	Prepaid Insurance PrepaidInsurance	94500	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	20631	usd
CY2024Q3	us-gaap	Prepaid Rent PrepaidRent	59426	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	0	usd
CY2024Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4167	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	0	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	158093	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	120631	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7738	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7738	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6997	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6484	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	741	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1254	usd
	us-gaap	Depreciation Depreciation	513	usd
	us-gaap	Depreciation Depreciation	1407	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	434327	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	88954	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	345374	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y29D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1149	pure
CY2024Q3	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	347947	usd
CY2024Q3	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	311048	usd
CY2024Q3	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	36899	usd
CY2024Q3	UMAC	Fair Value Of Warrant Liability FairValueOfWarrantLiability	315303	usd
CY2024Q3	UMAC	Fair Value Of Warrant Liability FairValueOfWarrantLiability	308964	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	6340	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	us-gaap	Restricted Stock Expense RestrictedStockExpense	679699	usd
	UMAC	Unrecognized Stock Compensation Expense UnrecognizedStockCompensationExpense	496661	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1461876	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	330000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	692500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
	UMAC	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue	0
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	692500	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.26
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1000000	usd
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	630000	shares
	us-gaap	Debt Instrument Convertible Stock Price Trigger DebtInstrumentConvertibleStockPriceTrigger	1.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y10M6D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-008108-index-headers.html	Edgar Link	pending
0001683168-24-008108-index.html	Edgar Link	pending
0001683168-24-008108.txt	Edgar Link	pending
0001683168-24-008108-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
umac-20240930.xsd	Edgar Link	pending
unusual_ex3101.htm	Edgar Link	pending
unusual_ex3102.htm	Edgar Link	pending
unusual_ex3201.htm	Edgar Link	pending
unusual_ex3202.htm	Edgar Link	pending
unusual_i10q-093024.htm	Edgar Link	pending
umac-20240930_def.xml	Edgar Link	unprocessable
umac-20240930_lab.xml	Edgar Link	unprocessable
umac-20240930_pre.xml	Edgar Link	unprocessable
unusual_i10q-093024_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
umac-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UMAC
Unusual Machines, Inc. Stock $umac

2024 Q4 Form 10-Q Financial Statement

#000168316824008108 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UMAC Unusual Machines, Inc. Stock $umac

2024 Q4 Form 10-Q Financial Statement

#000168316824008108 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UMAC
Unusual Machines, Inc. Stock $umac